Published Date: 02 Mar 2023
Many doctors have accused hospitals and large hospitals of opposing quality care and promoting violence. Others disagree.
Read Full NewsSwiss generic drugmaker Sandoz filed a draft anti-dumping complaint with the European Commission over Chinese imports of the antibiotic ingredient amoxicillin.
Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.
Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.
An observational study suggests that bone mineral density may serve as a marker of systemic health.
Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.
The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.
Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.
1.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
2.
Study Finds Microplastics Near Tumors; Experts Doubt Results
3.
Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer
4.
Research indicates that combining AI models enhances the ability to predict breast cancer risk.
5.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
1.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
2.
Understanding Pomalidomide: A promising drug for multiple myeloma treatment
3.
Understanding Colon Cancer: Symptoms, Causes, and Treatment Options
4.
The Mysterious World of Petechiae: Exploring Causes and Treatments
5.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
3.
Navigating the Complexities of Ph Negative ALL - Part VIII
4.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation